Transaction Details

January 6, 2017


Capital Goods and Heavy Industries, Healthcare, Industrials and Industrial Technology

Deal Type

Minority Investment

Deal Value


Previous Next

GCA Advises LDC on its Minority Investment in ChargePoint Technology Holdings

GCA Advises LDC on Its Minority Investment in ChargePoint Technology Holdings

We are pleased to announce our client, the private equity firm LDC, has completed a minority investment in ChargePoint Technology Holdings Limited (ChargePoint), a high growth manufacturer and innovator of specialist high containment and sterile transfer valves.
ChargePoint, which is headquartered in Liverpool, UK, manufactures and supplies its products to the largest global pharmaceutical, biopharmaceutical and chemicals companies. Operating across Europe, Asia and North America, its patented technology is used in the development and production of medicines and vaccines by the top 50 Global Pharmaceutical manufacturers, facilitating the safe transfer of highly potent and sterile powders.

GCA acted as exclusive financial advisor to LDC in connection with this transaction.

Previous Next
All Transactions